<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP
        </div>
        <div class="card-body">
                <p>This study assessed the possibility to build a prognosis predictor, based on microarray gene expression measures, in stage II and III colon cancer patients. Tumour (T) and non-neoplastic mucosa (NM) mRNA samples from 18 patients (nine with a recurrence, nine with no recurrence) were profiled using the Affymetrix HGU133A GeneChip. The k-nearest neighbour method was used for prognosis prediction using T and NM gene expression measures. Six-fold cross-validation was applied to select the number of neighbours and the number of informative genes to include in the predictors. Based on this information, one T-based and one NM-based predictor were proposed and their accuracies were estimated by double cross-validation. In six-fold cross-validation, the lowest numbers of informative genes giving the lowest numbers of false predictions (two out of 18) were 30 and 70 with the T and NM gene expression measures, respectively. A 30-gene T-based predictor and a 70-gene NM-based predictor were then built, with estimated accuracies of 78 and 83%, respectively. This study suggests that one can build an accurate prognosis predictor for stage II and III colon cancer patients, based on gene expression measures, and one can use either tumour or non-neoplastic mucosa for this purpose.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M6046">M6046</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:11258">ncbigene:11258</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8992">ncbigene:8992</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1163">ncbigene:1163</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:79752">ncbigene:79752</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51138">ncbigene:51138</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9412">ncbigene:9412</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4189">ncbigene:4189</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9550">ncbigene:9550</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3576">ncbigene:3576</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3015">ncbigene:3015</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:79590">ncbigene:79590</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6782">ncbigene:6782</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4321">ncbigene:4321</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4067">ncbigene:4067</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:11235">ncbigene:11235</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9140">ncbigene:9140</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M6046&#39;, name=&#39;BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP&#39;), definition=&#39;This study assessed the possibility to build a prognosis predictor, based on microarray gene expression measures, in stage II and III colon cancer patients. Tumour (T) and non-neoplastic mucosa (NM) mRNA samples from 18 patients (nine with a recurrence, nine with no recurrence) were profiled using the Affymetrix HGU133A GeneChip. The k-nearest neighbour method was used for prognosis prediction using T and NM gene expression measures. Six-fold cross-validation was applied to select the number of neighbours and the number of informative genes to include in the predictors. Based on this information, one T-based and one NM-based predictor were proposed and their accuracies were estimated by double cross-validation. In six-fold cross-validation, the lowest numbers of informative genes giving the lowest numbers of false predictions (two out of 18) were 30 and 70 with the T and NM gene expression measures, respectively. A 30-gene T-based predictor and a 70-gene NM-based predictor were then built, with estimated accuracies of 78 and 83%, respectively. This study suggests that one can build an accurate prognosis predictor for stage II and III colon cancer patients, based on gene expression measures, and one can use either tumour or non-neoplastic mucosa for this purpose.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;16091735&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;11258&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8992&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1163&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;79752&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51138&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9412&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4189&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9550&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3576&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3015&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;79590&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6782&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4321&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4067&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;11235&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9140&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Leona Saunders&#39;], &#39;exact_source&#39;: [&#39;Table 2: Overexpressed genes in patients who developed a recurrence&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>